Biotechnology News and Research

RSS

Plant-based vaccine against SARS-CoV-2 shows promise

Researchers at Canadian biotechnology company Medicago report that Phase 1 trials of a plant-based vaccine for SARS-CoV-2 are underway and showing promise.

21 May 2021

Biognosys Announces the Appointment of Kristina Beeler as Chief Business Officer

Biognosys announces the appointment of Kristina Beeler as Chief Business Operator

From Biognosys 21 May 2021

Plant-produced COVID-19 vaccine shows potent immunogenic profile in humans

An interim report on a phase 2 clinical trial indicates both the safety and efficacy of a plant-produced virus-like particle vaccine candidate against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The vaccine candidate has shown an acceptable safety profile and high potency in inducing humoral and cellular immune responses in adults (18 – 64 years) and elderly (65 years and above) individuals. The report is currently available on the medRxiv* preprint server.

20 May 2021

Scientists provide a new approach to model infectious diseases

In the midst of a devastating global pandemic of wildlife origin and with future spillovers imminent as humans continue to come into closer contact with wildlife, infectious-disease models that consider the full ecological and anthropological contexts of disease transmission are critical to the health of all life.

19 May 2021

New imaging technique helps reveal the best antibodies for COVID-19 detection

Vaccines are turning the tide of the pandemic, but the risk of infection is still present in some situations. If you want to visit a friend, get on a plane, or go see a movie, there is no highly accurate, instant test that can tell you right then and there whether or not you have a SARS-CoV-2 infection.

18 May 2021

Fasting diets could have detrimental effect on the health of future generations

Fasting diets could impact the health of future generations according to new research from the University of East Anglia (UEA).

17 May 2021

Researchers identify new compound that may prevent cardiac arrhythmia risk from common drugs

Dozens of commonly used drugs, including antibiotics, antinausea and anticancer medications, have a potential side effect of lengthening the electrical event that triggers contraction, creating an irregular heartbeat, or cardiac arrhythmia called acquired Long QT syndrome.

14 May 2021

South Australian immunologist receives $3 million to accelerate work on Covid-19 vaccine

A leading South Australian immunologist has been awarded $3 million from the Federal Government to accelerate work on a locally developed Covid-19 vaccine, in what's anticipated to be the second line of defence against the virus.

13 May 2021

New method to efficiently deliver drugs into cells

A new, patented method called Progressive Mechanoporation makes it possible to mechanically disrupt the membranes of cells for a short time period and let drugs or genes inside cells.

12 May 2021

Study confirms rare blood clotting risk linked to ChAdOx1-S vaccine - benefits still outweigh risks

New research published in BMJ confirmed evidence of blood clotting finding a small risk after receiving one Oxford-AstraZeneca ChAdOx1-S severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine.

12 May 2021

New approach targeting viral RNA could lead to broad spectrum anti-viral drugs

A new approach to tackling viruses by targeting the 'control center' in viral RNA could lead to broad spectrum anti-viral drugs and provide a first line of defense against future pandemics, according to new research at the University of Birmingham.

11 May 2021

New "molecular tweezers" can help combat antibiotic-resistant bacteria

Researchers from Ben-Gurion University (BGU), together with American and German colleagues, have developed new "molecular tweezers" to combat antibiotic-resistant bacteria. Their recently announced findings were published in Cell Chemical Biology.

10 May 2021

Targeted therapies could exploit unique metabolic features of pancreatic cancer cells

Probing the unique biology of human pancreatic cancer cells in a laboratory has yielded unexpected insights of a weakness that can be used against the cells to kill them.

7 May 2021

A single archaeal enzyme can produce a spectacular range of natural and non-natural cardiolipins

Cells of all life forms are surrounded by a membrane that is made of phospholipids. One of these are the cardiolipins, which form a separate class due to their unique structure.

7 May 2021

Study: Novavax Covid-19 vaccine is efficacious against the B.1.351 South African variant

The published data provide additional detail of an initial analysis conducted in January, while more robust data from a complete analysis of the study was subsequently shared in March 2021.

6 May 2021

Nanoscope presents optical gene delivery, OCT-guided electrophysiology platforms at ARVO annual meeting

Nanoscope Technologies LLC, a biotechnology company developing gene therapies for treatment of retinal diseases, is featuring multiple scientific presentations highlighting its groundbreaking research on optical gene delivery for vision restoration and OCT-guided electrophysiology platforms for characterization of retinal degeneration and assessment of efficacy of cell-gene therapy at the 2021 ARVO annual (virtual) meeting, May 1-7.

5 May 2021

Novel CBD analog alleviates pain in mouse model of chemotherapy-induced peripheral neuropathy

For patients with chronic pain, ineffective treatments, lowered work productivity, and other factors often coalesce, fueling feelings of hopelessness and anxiety and setting the stage for even bigger problems, including substance use disorders.

5 May 2021

Researchers reach new milestone in the development of effective malaria vaccine

Sanaria PfSPZ-CVac" is a live vaccine consisting of infectious Plasmodium falciparum (Pf) malaria parasites that are injected into the subject at the same time as they receive an antimalarial drug.

5 May 2021

Researchers develop new technology to reduce high error rates in gene sequencing

Next-generation gene sequencing (NGS) technologies --in which millions of DNA molecules are simultaneously but individually analyzed-- theoretically provides researchers and clinicians the ability to noninvasively identify mutations in the blood stream.

4 May 2021

Pioneering neural recordings lay the groundwork for personalized Parkinson's treatments

Pioneering neural recordings in patients with Parkinson's disease by UC San Francisco scientists lays the groundwork for personalized brain stimulation to treat Parkinson's and other neurological disorders.

4 May 2021

Biotechnology News and Research

Plant-based vaccine against SARS-CoV-2 shows promise

Biognosys Announces the Appointment of Kristina Beeler as Chief Business Officer

Plant-produced COVID-19 vaccine shows potent immunogenic profile in humans

Scientists provide a new approach to model infectious diseases

New imaging technique helps reveal the best antibodies for COVID-19 detection

Fasting diets could have detrimental effect on the health of future generations

Researchers identify new compound that may prevent cardiac arrhythmia risk from common drugs

South Australian immunologist receives $3 million to accelerate work on Covid-19 vaccine

New method to efficiently deliver drugs into cells

Study confirms rare blood clotting risk linked to ChAdOx1-S vaccine - benefits still outweigh risks

New approach targeting viral RNA could lead to broad spectrum anti-viral drugs

New "molecular tweezers" can help combat antibiotic-resistant bacteria

Targeted therapies could exploit unique metabolic features of pancreatic cancer cells

A single archaeal enzyme can produce a spectacular range of natural and non-natural cardiolipins

Study: Novavax Covid-19 vaccine is efficacious against the B.1.351 South African variant

Nanoscope presents optical gene delivery, OCT-guided electrophysiology platforms at ARVO annual meeting

Novel CBD analog alleviates pain in mouse model of chemotherapy-induced peripheral neuropathy

Researchers reach new milestone in the development of effective malaria vaccine

Researchers develop new technology to reduce high error rates in gene sequencing

Pioneering neural recordings lay the groundwork for personalized Parkinson's treatments

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News